Approved Study Database

Ref. No. Scientific Title Principal investigator
2022.361 Safety and clinical and virologic outcomes in COVID-19 patients with chronic kidney disease treated with nirmatrelvir-ritonavir Dr. CHOW Kai Ming
周啟明
2023.123 HLA-typing of donor-origin cells enriched from urine-derived cell culture of kidney transplanted recipients Dr. CHOW Kai Ming
2009.481 Effect of Icodextrin on the Treatment Outcome of Peritoneal Dialysis Patients During Acute Peritonitis Dr Chow Kai Ming
2017.296 Patient discharge information survey on inpatient service Dr. CHOW Kai Ming
周啟明
2017.147 Effect of Erythropoiesis-Stimulating Agent therapy in Patients Receiving Palliative Care of Chronic Kidney Disease Dr. CHOW Kai Ming
周啟明
2015.197 Randomized Controlled Trial of Straight versus Coiled Peritoneal Dialysis Catheter for Peritoneal Dialysis Patients Dr. CHOW Kai Ming
周啟明
2016.067 A practice model to enhance the provision of nursing care to manage sexual functioning in gynaecological cancer patients in Hong Kong Dr. CHOW Ka Ming
周嘉明
2017.087 A risk prediction model to identify and motivate high-risk women for endometrial cancer screening in Hong Kong Dr. CHOW Ka Ming
周嘉明
2017.098 Development of a practice model to promote medication safety and prevent drug administration errors Dr. CHOW Ka Ming
周嘉明
2017.692 A culturally-adapted Women’s Wellness After Cancer programme for reducing psychological distress and improving health-related quality of life among Hong Kong gynaecological cancer survivors Dr. CHOW Ka Ming
周嘉明
2015.343 The use of traditional Chinese medicine in preventing and managing oral ulcers: a feasibility study Prof. CHOW Ka Ming
周嘉明
2016.192 Developing a multi-disciplinary psycho-educational intervention programme for infertile Hong Kong women planning for IVF to reduce psychological distress and improve marital relationships and pregnancy rates Prof. CHOW Ka Ming
周嘉明
2014.501 A randomized controlled trial of psycho-educational interventions for reducing uncertainty and anxiety, and improving sexual functioning among gynecological cancer patients in Hong Kong Dr. CHOW Ka Ming
2023.357 An Empirical Research of a Multimodal Decision Aid to Support Shared Decision-Making among Women Newly Diagnosed with Breast Cancer Dr. CHOW Ka Ming
2021.350 Aetiology and treatment of breast pain in Hong Kong Chinese lactating mothers: A prospective cohort study Dr. CHOW Ka Ming
周嘉明
2022.416 Randomised controlled trial of a multimodal couple-coping intervention to enhance couples’ sexual adjustment after treatment for premenopausal breast cancer Dr. CHOW Ka Ming
2021.276 A multimodal cancer rehabilitation programme promoting sense of coherence for women treated for gynaecological cancer: A randomised controlled trial Dr. CHOW Ka Ming
周嘉明
2022.430 A proactive child protection programme for mothers with psychological distress: A pilot project with outcome evaluation Dr. CHOW Ka Ming
2012.471 A randomized controlled trial of psychoeducational interventions for improving sexual functioning, quality of life, and psychological outcomes among gynecological cancer patients in Hong Kong Ms Chow Ka Ming
2012.336 Psychoeducational interventions for gynecological cancer patients in Hong Kong Ms Chow Ka Ming
2018.112 Rebuilding sexuality and intimacy after treatment for gynaecological cancer, through a nurse-led sexual rehabilitation intervention: a randomised controlled trial Dr. CHOW Ka Ming
周嘉明
2019.135 Counselling practicum for community clients with mental illness Ms. CHOW Jessie King Yan
周景欣
2018.562 Efficacy of Mindfulness Born Peace and Happiness (MBPH) – a new Mindfulness-based Intervention based on the teachings of Thich Nhat Hanh: A randomized controlled trial on common mental disorders Ms. CHOW Jackie Cheuk Kwan
周卓君
2017.029 The effect of a new ankle foot orthosis on gait symmetry for stroke patient Mr. CHOW Hung Yu
周鴻譽
2008.537 Patients Phsyiotherapist I Chow Hon Yuen
2012.274 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate Cardiovascular Outcomes of TAK-875, 50 mg in Addition to Standard of Care in Subjects with Type 2 Diabetes and with Cardiovascular Disease or Multiple Risk Factors for Cardiovascular Events Dr. CHOW Francis Chun-Chung
2009.533 BOOST: INTENSIFY ALL A Pan Asian trial comparing efficacy and safety of NN5401 and biphasic insulin aspart 30 in type 2 diabetes. A 26-week trial, randomised, open-label, two-arm, parallel-group, treat-to-target study comparing efficacy and safety of the soluble insulin analogue combination (SIAC) twice daily with biphasic insulin aspart 30 twice daily, with or without metformin in subjects with type 2 diabetes in inadequate glycaemic control on once or twice daily insulin regimen with or without metformin Dr Chow Francis Chun-Chung
2009.532 BEGIN: ONCE ASIA A Pan Asian trial comparing efficacy and safety of insulin NN1250 and insulin glargine as add on to OAD(s) in subjects with type 2 diabetes. A 26-week randomised, confirmatory, controlled, open label, multicentre, multinational treat-to-target trial comparing the efficacy and safety of SIBA and insulin glargine, both injected once daily as add on to current OAD treatment in insulin na・e subjects with type 2 diabetes mellitus qualifying for more intensified treatment Dr Chow Francis Chun-Chung
2009.144 SCALE -Obesity and Pre-diabetes Satiety and Clinical Adiposity- Liraglutide Evidence in Nondiabetic and Diabetic Subjects Effect of liraglutide on body weight in non-diabetic obese subjects or overweight subjects with comorbidities A randomised, double-blind, placebo controlled, parallel group, multi-centre, multinational trial with stratification of subject to either 56 or 160 weeks of treatment based on pre-diabetes status at randomisation Dr. CHOW Francis Chun Chung
2010.511 A multicentre, international, randomised, parallel group, double blind study to evaluate Cardiovascular safety of linagliptin versus glimepiride in patients with type 2 diabetes mellitus at high cardiovascular risk. The CAROLINA Trial. Dr. CHOW Francis Chun Chung
2013.409 Efficacy and safety of semaglutide once-weekly versus sitagliptin once-daily as add-on to metformin and/or TZD in subjects with type 2 diabetes Dr. CHOW Francis Chun Chung
2015.370 A 24-week, multinational, multicentre, randomised, open label, parallel-group treat to target trial to compare efficacy and safety of thrice daily versus twice daily NovoMix®30 (Biphasic insulin aspart 30) in subjects with type 2 diabetes inadequately controlled with basal insulin Dr. CHOW Francis Chun Chung
周振中
2017.233 Efficacy and safety of semaglutide once-weekly versus sitagliptin once-daily as add-on to metformin in subjects with type 2 diabetes Dr. CHOW Francis Chun Chung
周振中
2015.470 Efficacy and safety of semaglutide versus dulaglutide as add-on to metformin in subjects with type 2 diabetes Dr. CHOW Francis Chun Chung
周振中
2007.494 A Randomised, Double-blind, Active-Controlled Parallel Group Efficacy and Safety Study of BI 1356 (5.0 mg, administered orally once daily) Compared to Glimepiride (1 to 4 mg once daily) Over Two Years, In Type 2 Diabetic Patients with Insufficient Glycaemic Control Despite Metformin Therapy Dr. Chow Francis C. C.
2018.526 A randomized, 24 week, active-controlled, open-label, 3-arm, parallel-group multicenter study comparing the efficacy and safety of iGlarLixi to insulin glargine and lixisenatide in type 2 diabetes mellitus patients insufficiently controlled with oral antidiabetic drug(s) Dr. CHOW Elaine Yee Kwan
周怡君
2019.222 The effect of real-time continuous glucose monitoring (rtCGM) on improving time-in-range in suboptimally controlled type 2 diabetes patients on multiple daily injections (MDI) Dr. CHOW Elaine Yee Kwan
周怡君
2022.464 A study of the safety and tolerability of gold nanoparticles in a topical hydrogel in healthy volunteers Dr. CHOW Elaine Yee Kwan
2021.709 A Multi-center, Randomized, Double-Blinded, Parallel, Vildagliptin and Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of PB-201 in Treatment-naive Patients with Type 2 Diabetes Mellitus Prof. CHOW Elaine Yee Kwan
周怡君
2022.293 A Multi-center, Randomized, Double-Blinded, Parallel and Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients with Poor Glycemic Control via Metformin Hydrochloride Monotherapy Prof. CHOW Elaine Yee Kwan
2021.716 The Impact of High or Low FODMAP diets on Postprandial glucose response and Gut Microbiota in Individuals with Prediabetes treated with Metformin: A Randomized Crossover Controlled-Feeding Trial Dr. CHOW Elaine Yee Kwan
周怡君
2019.605 Continuous glucose monitoring as an adjunct to lifestyle modification in individuals with impaired glucose tolerance: a randomised controlled trial Dr. CHOW Elaine Yee Kwan
周怡君
2019.352 A Phase Ib/IIa, Single Ascending Dose Study of the Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients with Type 2 Diabetes Mellitus Dr. CHOW Elaine Yee Kwan
2018.106 Targeted screening for familial hypercholesterolaemia in Hong Kong Chinese patients with established coronary artery disease Dr. CHOW Elaine Yee Kwan
周怡君
2018.621 Randomised controlled trial of flash glucose monitoring in reduction of hypoglycaemia in diabetes patients with chronic kidney disease Dr. CHOW Elaine Yee Kwan
周怡君
2020.312 Effectiveness and Safety Study of the Continuous Glucose Monitoring System for Home Use (Including In-clinic sessions) in Patients with Diabetes Prof. CHOW Elaine Yee Kwan
2015.563 Beta cell function and insulin sensitivity in Chinese with young onset type 2 diabetes and their siblings – a pilot study Dr. CHOW Elaine Yee Kwan
2016.572 Effectiveness and safety study of the percutaneous optical fibre glucose sensor (FiberSense) for home use in diabetic and prediabetic individuals Dr. CHOW Elaine Yee Kwan
2017.359 A pilot study to describe the glycemic variability of insulin glargine 300U/ml versus NPH (Neutral Protamine Hagedorn) in the insulin-naive type 2 diabetes patients following a patient-adjusted insulin algorithm in Hong Kong Dr. CHOW Elaine Yee Kwan
2011.235 Genetic analysis of familial hypercholesterolaemia in Hong Kong Chinese population Dr. CHOW Elaine Yee Kwan

Page 169 of 254.